C57BL/6J-Lrrk2em1(EGFP-IRES-Bromotag)H/H

Status

Available to order

EMMA IDEM:16084
Citation informationRRID:IMSR_EM:16084 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6J-Lrrk2em1(EGFP-IRES-Bromotag)H/H
Alternative nameC57BL/6J-Lrrk2/H
Strain typeEndonuclease-mediated
Allele/Transgene symbolLrrk2em1(EGFP-IRES-Bromotag)H
Gene/Transgene symbolLrrk2

Information from provider

ProviderReva Biju
Provider affiliationMary Lyon Centre at MRC Harwell
Genetic informationThis strain carries a knock-in of EGFP-IRES-Bromotag into exon ENSMUSE00000503724 of the Lrrk2 gene made by Pronuclear injection of CRISPR/Cas9 reagents, SgRNA protospacer sequence CTGACAGGCGCCACTGGCCA and GCCGGCTGCACCATGGCCAG, a PAM sequence TGG, and a donor oligo sequence carrying the BromoTag into 1-cell stage embryos. This strain can be useful for studying the role of LRRK2 and the LRRK2 pathway in the pathogenesis of Parkinson's disease.
Phenotypic informationHomozygous:
LRRK2 phosphorylates a subgroup of Rab GTPase proteins (including Rab10 and Rab12). These proteins when phosphorylated, interact with RILPL1 which intereferes with Ciliogenesis and disrupts the Sonic hedgehog neuroprotective circuit that supports dopaminergic neurons. Studying the role of LRRK2 and the LRRK2 pathway may therefore be useful in studying the pathogenesis of Parkinson's disease. This strain shows a significant reduction in the LRRK2 protein levels in all tissue types in homozygotes. The decreased expression of LRRK2 leads to lower phosphorylation levels of Rab10 and Rab12 thus suggesting that the LRRK2-BromoTag knock-in impacts basal LRRK2 levels. (further phenotyping data in attached file)

Heterozygous:
In heterozygous animals, decreased expression of LRRK2 leads to lower phosphorylation levels of Rab10 and Rab12 thus suggesting that the LRRK2-BromoTag knock-in impacts basal LRRK2 levels.
Breeding historyThis strain is coisogenic on C57BL/6J
ReferencesNone available
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching


Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).